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Using analytical gel filtration (FPLC) we show here that avian gizzard caldesmon (chain molecular mass 
150 kDa) self-associates to form end-to-end dimers. Increasing salt concentration promotes dimerisation: 
at 150 mM KCl, about 40% of the caldesmon was dimeric. Freshly gel filtered caldesmon had an actin gelat- 
ing activity which decreased with increasing ionic strength. At 150 mM KCl, caldesmon at a 1:90 molar 
ratio to actin doubled the low shear viscosity of F-actin. Sixfold less filamin was required to produce the 
same effect. 
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1. INTRODUCTION 
Caldesmon is a heat stable 150 kDa actin- 
binding protein first isolated from smooth muscle 
[li, but present in a wide variety of cells [2]. Both 
its molecular conformation and its function are 
currently controversial. On the one hand it has 
been suggested to be a regulatory protein partly 
analogous to the troponin complex of skeletal 
muscle [3]. Caldesmon effects, in vitro and in the 
absence of calcium, an approx. 3-fold inhibition of 
the tropomyosin-actin-activated ATPase of 
myosin [4]. The binding of Ca-calmodulin to 
caldesmon has been found to relieve this inhibition 
[4], although probably not [3] in the simple flip- 
flop manner originally proposed [4]. On the other 
hand, caldesmon has been suggested to be an F- 
actin crosslinking protein. This proposal was first 
made by the discoverer of caldesmon [5], but later 
retracted on his finding [6] that freeze-thawed 
material had greater gelation activity than freshly 
prepared caldesmon. Correspondingly, a report 
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that caldesmon is an F-actin bundling protein [7] 
has been qualified by its author after it was found 
that bundling appeared due to artefactual thiol- 
crosslinking of caldesmon [8]. Finally, there are 
reports that phosphorylation of caldesmon can 
reduce its inhibitory activity [9], and that 
phosphorylated caldesmon inhibits myosin light 
chain kinase [lo]. 
Resolution of caldesmon’s true structure and 
function depends heavily on reliable determination 
of the conformational state of the molecule in 
solution. Caldesmon was first thought to be a 
300 kDa globular dimer [ 11. Combined gel filtra- 
tion and sucrose gradient centrifugation indicated 
an elongated monomer of Stokes radius 90 nm [7]. 
Our own low-angle rotary shadowing data sug- 
gested an elongated monomer which could form 
dimers in the 50% glycerol buffers used for elec- 
tron microscopy [I 11. Here we establish, using 
analytical gel filtration (FPLC), that caldesmon 
monomers associate to end-to-end dimers in solu- 
tion at physiological ionic strength, and that the 
gel-filtered material does have a substantial effect 
on the low shear viscosity of F-actin. The data are 
consistent with caldesmon being an elongated, 
dimeric protein which has the capacity to crosslink 
F-actin. 
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2. MATERIALS AND METHODS 
2.1. Preparation of caldesmon 
We used a method slightly modified from that of 
Bretscher [7] to prepare turkey gizzard caldesmon. 
About 500 g finely minced muscle was washed 
twice at 4°C in 1 1 of 40 mM KCl, 10 mM im- 
idazole, 2 mM MgCl2, 0.5 mM dithiothreitol 
(DTT), 0.2 mM EGTA, pH 6.5, using a Sorvall 
Omnimixer for resuspension and 10000 x g cen- 
trifugations for 30 min. The washed muscle was 
then similarly extracted with 25 mM MgCl2, 
40 mM KCl, 20 mM imidazole, 0.5 mM DTT, 
0.5 mM EGTA, pH 7.5. The supernatant follow- 
ing centrifugation was brought rapidly to boiling 
point using a microwave oven and again centri- 
fuged. The 30-55% ammonium sulphate cut of 
the resulting supernatant was dissolved in and 
dialysed against the wash buffer, and then applied 
to a 150 ml column of Q Sepharose in wash buffer. 
Elution was with a 2 x 500 ml gradient of 
40-500 mM KC1 in wash buffer at a flow rate of 
250 ml/h. Electrophoretically pure caldesmon 
eluted ahead of tropomyosin, and was used 
without further purification. 
2.2. Preparation of actin 
Rabbit skeletal muscle F-actin was prepared ac- 
cording to [12], with a final gel filtration over 
Sephadex G-25. 
2.3. Preparation of filamin 
Turkey gizzard filamin was prepared from the 
residue remaining after caldesmon extraction. This 
residue was extracted with LAMES [ 1 l] and the 
supernatant following centrifugation made to 
25 mM MgCl2 and left overnight at 4°C. The 
resulting actomyosin precipitate was pelleted, and 
the 20-40% ammonium sulphate cut of the super- 
natant dialysed into 5 mM Tris-acetate, 0.1% 
2-mercaptoethanol, pH 7.6. The dialysate was 
clarified (18000 x g, 30 min), and applied to a col- 
umn of DEAE-Sepharose 6B-Cl equilibrated in the 
same buffer. The column was eluted with a 
O-O.3 M KC1 gradient, the filamin-containing 
fractions were pooled, concentrated by precipita- 
tion at 55% ammonium sulphate, dialysed into 
30 mM KCI, 0.15 mM DTE, 1 mM MgCl2, 5 mM 
imidazole, pH 7.3, and applied to a Sephacryl 
S-300 column equilibrated in the same buffer. 
Filamin-containing fractions were used directly, or 
further purified as necessary over a hydroxyapatite 
column. 
2.4. Preparation of calmodulin 
Bovine brain calmodulin was prepared ac- 
cording to [14] with slight modifications [l 11. 
3. RESULTS 
3.1. Solution structure of caldesmon 
The available hydrodynamic data [7] indicate 
that caldesmon is an elongated monomer of Stokes 
radius 90 nm. Analytical gel filtration (FPLC, 
Superose 6 column) of caldesmon confirmed that 
this was the case at 60 mM KC1 concentration 
(fig.1). However as the salt concentration was 
raised a leading shoulder and then a distinct peak 
appeared on the chromatogram ahead of the major 
peak, in a position corresponding to a doubling of 
the monomer Stokes radius (fig. 1). Additionally 
the major peak was shifted so as to indicate an in- 
crease in the Stokes radius of the monomer at 
higher salt concentrations. The results demonstrate 
that caldesmon monomers can self-associate into 
dimers having twice the monomer Stokes radius. 
These must correspond to the end-to-end dimers 
visualised by electron microscopy [ 111. Dimer and 
monomer appeared as quite distinct peaks, rather 
than as a broadened peak of intermediate mobility. 
This suggests that caldesmon did not transit rapid- 
ly between monomer and dimer states on the time 
scale of the experiments (40 min for one FPLC 
run). Interestingly, the mobility of the caldesmon 
dimer species on the columns corresponded closely 
to that of filamin, and the caldesmon monomer 
species to that of heavy merofilamin [16] (filamin 
‘monomer’). Caldesmon and filamin thus appear 
to have similar Stokes radii. They appear very 
similar in low-angle Pt rotary shadowing [1 11, in 
spite of their substantially different chain 
molecular masses (filamin is 250 kDa), consistent 
with caldesmon having a lower mass/unit length 
than filamin. 
Note that the FPLC runs were performed by ap- 
plying identical samples of gizzard caldesmon to 
columns preequilibrated at the various different 
salt concentrations. Following the high salt runs in 
which dimers were observed, application of a fur- 
ther aliquot of sample to a low salt column 
307 
Volume 219, number 2 FEBS LETTERS July 1987 
II CALDESMON 
Fig. 1. Analytical gel filtration. Caldesmon (lower 3 
traces) was stored at a concentration of 1 mg/ml in 
150 mM KCI Q-Sepharose buffer and was freshly 
filtered through 0.22 PM miilipore membranes before 
application of 200~1 aliquots to HR lo/30 columns of 
Superose 6, preequilibrated at the salt concentrations 
indicated. Other buffer constituents were held constant. 
Elution was at 0.5 ml/min, corresponding to an 
operating pressure of about 0.5 MPa. The column was 
calibrated using Sigma globular protein standards, and 
a plot of Kd vs log M, was linear at the flow rate used. 
The void volume was determined with Blue dextran, and 
the included volume with acetone. Filamin (upper traces) 
was run similarly. 
reproduced the original single peak (fig.la), ex- 
cluding thereby that the observed dimerisation was 
a result of time-dependent formation of S-S 
bridges [8] between monomers. Addition of excess 
bovine brain calmodulin to the sample (5 mol 
calmodulin/mol caldesmon, 150 mM salt buffer) 
did not detectably affect the dimerisation in either 
the presence or absence of 100,uM Ca. 
3.2. Effects of caldesmon on F-actin viscosity 
The finding that caldesmon can reversibly 
dimerise raises the possibility that a functional 
caldesmon dimer could interact equivalently with 
two different actin filaments. There have been 
previous reports of an effect of caldesmon on the 
viscosity of F-actin, but their significance has been 
confused by the tendency of caldesmon toward ag- 
gregation. The experiments described above pro- 
vided material of defined conformation, which 
was immediately tested for its effect on F-actin 
viscosity. 
Freshly gel-filtered caldesmon from either the 
leading or trailing component of the double peak 
(fig. lc) increased the low-shear viscosity of F-actin 
(fig.2). The two fractions had closely similar ef- 
fects, with an increase in potency as the salt con- 
centration was lowered. At physiological ionic 
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Fig.2. Low-shear viscometry. Gel-filtered G-actin in a 
buffer of 2 mM Tris, 0.2 mM ATP, 0.5 mM 2-MCE, 
0.2 mM CaCl2, 0.005% NaN3, pH 8.0, was polymerised 
in 100 ~1 capillaries at 25°C by the addition of MgClz to 
5 mM and varying amounts of 3 M KCI, in either the 
presence or absence of freshly gel-filtered caldesmon. 
The molar ratio of caldesmon to actin monomer was 
1:90, assuming a molecular mass for caldesmon of 
300 kDa. After 1 h at 25”C, triplicate capillaries were 
clamped at 60” to the vertical, and the descent rate for 
0.64 mm stainless steel balls rolling under gravity at 
25°C was recorded. Relative viscosity is the ratio of the 
descent rates for caldesmon-actin to those of 
appropriate actin-only controls. (0) Caldesmon from 
the trailing (monomer) peak obtained by FPLC gel 
filtration at 150 mM KC1 buffer. (0) Caldesmon from 
the corresponding leading (dimer) peak. 
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caldesmon dimer to 90 actin monomers was 
enough to double the low-shear viscosity of F-actin 
(fig.2). For comparison, filamin produced under 
the same conditions an equivalent effect at a six- 
fold lower molar ratio to actin. 
4. DISCUSSION 
Here we have established that in solution at 
physiological ionic strength caldesmon forms non- 
covalently linked dimers, that this material does in- 
crease F-actin low-shear viscosity, but that the 
activity is highly salt dependent and hence easy to 
overlook. Marston and Smith [3] have emphasised 
the strong influence of temperature and ionic con- 
ditions on caldesmon-actin interactions. Combina- 
tion of their data with our own suggests that 
increasing salt concentration to physiological evels 
has the dual effect of weakening the binding of 
caldesmon to actin and strengthening caldesmon’s 
end-to-end self-association. The net effect is ap- 
parently to produce a slight negative dependence 
of the actin-gelating activity on salt concentration 
(fig.2). The present work thus reemphasises the 
need to concentrate attention on caldesmon’s 
behaviour in the physiological range of ionic con- 
ditions. That dimerisation becomes stronger with 
increasing ionic strength suggests an involvement 
of hydrophobic forces in stabilising the dimers. 
Calmodulin however had no detectable effect on 
the dimerisation. 
Concerning the function of caldesmon, we wish 
Fig.3. A notional model for the caldesmon-actin 
interaction. 
to suggest here a speculative model by which the 
present and much of the existing data can be recon- 
ciled. Important points are as follows. Firstly, the 
specific end-to-end dimerisation of caldesmon in- 
dicates that the two ends of the caldesmon 
monomer are nonequivalent. Secondly, chymo- 
tryptic cleavage of the caldesmon molecule 
generates an actin, tropomyosin and calmodulin- 
binding 40 kDa N-terminal fragment and a 
100 kDa C-terminal species [17,18], of unknown 
function, indicating that one end only of each 
caldesmon chain binds actin. Lastly, freshly gel 
filtered caldesmon increases F-actin low-shear (this 
work) and high-shear [l l] viscosity. Taken 
together, these data suggest he scheme outlined in 
fig.3, in which caldesmon is proposed to operate 
similarly to filamin [ 161 in making flexible 
crosslinks between adjacent actin filaments. Note 
however that in comparison to filamin, both 
caldesmon’s actin-binding and its dimerisation ap- 
pear relatively weak around physiological ionic 
strength, perhaps providing for slippage between 
linked actin filaments. Such a property might be 
consistent with an involvement of caldesmon in the 
observed slow relaxation of smooth muscle. In the 
scheme shown, the N-terminal domain of each 
150 kDa caldesmon chain would act under relaxing 
conditions to inhibit the actin-tropomyosin- 
activated myosin ATPase as described [17], whilst 
its C-terminal domain would associate with a part- 
ner on an adjacent actin filament and resist 
relaxation, 
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